# Richard B. Emmitt

> Richard B. Emmitt is a Series B investor at The Vertical Group backing Medical and Health Care. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [The Vertical Group](https://shizune.co/investors/profile/the-vertical-group)
- Location: Basking Ridge, United States
- Total investments: 2
- Last investment: Nov 2014
- Lead investor: 50%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/richard-emmitt-86153723

Richard B. Emmitt is a Series B investor at The Vertical Group in Basking Ridge focused on Medical and Health Care. Mr. Emmitt is a Managing Director of The Vertical Group, a New Jersey-based medical device venture capital partnership that succeeded the venture capital activities of F. Eberstadt & Co. Mr. Emmitt has been recognized as one of the leading experts on the healthcare industry, with more than thirty years’ experience in healthcare-related venturecapital, investment research, and investment banking.He currently serves on the board of several public and private medical device companies including BioSet, ENTrigue Surgical, Galil Medical, Incumed, and Tornier. During the past five years,Mr. Emmitt previously served on the board of directors of American Medical Systems, ev3 , Micro Therapeutics and Wright Medical Group..Mr. Emmitt was also involved in the successful development of SciMed Life Systems and Xomed Surgical Products, which were ultimately acquired by Boston Scientific and Medtronic, respectively.He holds an M.B.A from The Rutgers School of Business and a B.A. from Bucknell University.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 50% |
| Health Care | 1 | 50% |
| Medical Device | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Monteris Medical | Monteris Medical is a medical device venture that develops new technologies for the treatment of cancer. It is a private equity-backed neurosurgical company focused solely on diseases of the brain. It develops MRI-guided, laser-based systems designed for the ablation of brain lesions. The company's system applies focused laser energy to ablatebrain tumors from the inside, with little or no effect on surrounding healthy tissue as well as provides clinicians a new neurosurgical tool that offers real-time control and visualization of the therapy during laser ablation treatment, enabling neurosurgeons to ablate (treat with lethal heat) brain lesions and brain tumors that may be difficult to approach via traditional methods.It was founded in 1999 and has offices in Minneapolis, Minnesota, USA and Winnipeg, Manitoba, Canada. | $30M | Series B | Nov 13, 2014 |  |
| Galil Medical | Galil Medical is a new era of minimally invasive cryotherapy solutions that enhance patient quality of life. Galil Medical’s technology involves freezing and ablating diseased tissue in a technique referred to as cryotherapy, also referred to as cryoablation and cryosurgery.Galil Medical cryotherapy systems use compressed Argon gas to produceextremely low temperatures. As the gas passes through the cryoablation needle, the tip of the needle is cooled, forming an iceball, which engulfs the tumor and destroys the tissue. A variety of needle types is available to sculpt a freeze zone conformed to the tumor size and shape. Galil Medical cryosurgical systems precisely deliver sub-zero temperatures to target tissue with the aid of patented 17-gauge cryoablation needles and high-resolution imaging for the cryosurgical ablation of benign and cancerous tumors.Cryotherapy ablation has been widely used for prostate cancer treatment and kidney cancer treatment. New ablation treatments for various other tumors are being developed in the Women’s Health and Interventional Radiology markets. | $52M |  | Dec 11, 2006 |  |

2 of 2 investments shown.

## Co-investors
- [BDC Healthcare Venture](https://shizune.co/investors/profile/bdc-healthcare-fund) — VC Fund, 1 deal together
- [BDC Venture Capital](https://shizune.co/investors/profile/bdc-venture-capital) — VC Fund, 1 deal together
- [Investor Growth Capital Limited](https://shizune.co/investors/profile/investor-growth-capital) — VC Fund, 1 deal together
- [Thomas, McNerney & Partners](https://shizune.co/investors/profile/thomas-mcnerney-partners) — VC Fund, 1 deal together

## About The Vertical Group

VC Fund · Basking Ridge, United States

The Vertical Group is a New Jersey-based venture capital firm focused on the fields of medical technology and biotechnology.

4 contacts available at The Vertical Group.

| Name | Title | Profile |
| --- | --- | --- |
| Jack W. Lasersohn | General Partner | https://shizune.co/investors/profile/jack-w-lasersohn |
| John E. Runnells | General Partner | https://shizune.co/investors/profile/john-e-runnells |
| Richard B. Emmitt | Founder/Managing Director | https://shizune.co/investors/profile/richard-b-emmitt |
| Tony Chou | General Partner | https://shizune.co/investors/profile/tony-m-chou |

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Richard B. Emmitt invest in?

Richard B. Emmitt invests primarily in Medical, Health Care and Medical Device startups, most often at Series B stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Richard B. Emmitt last invest?

The most recent investment recorded for Richard B. Emmitt closed in Nov 2014. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co